Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Cohen

Showing results (1101-1110 of 1,179) with videos related to

Pageof 118
Sort By:
Thrombosis Research|November 26, 2016
Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trialsJan Beyer-Westendorf, Anthonie W A Lensing, Roopen Arya, et al.
Neurology|October 5, 2021
Hypothalamic Hamartomas: Evolving Understanding and ManagementNathan T Cohen, J Helen Cross, Alexis Arzimanoglou, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 18, 2015
Toxicity and clinical outcomes in patients with HIV on zidovudine and tenofovir based regimens: a retrospective cohort studySowmyanarayanan V Thuppal, Christine A Wanke, Farzad Noubary, et al.
Journal of Thrombosis and Thrombolysis|May 12, 2024
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register studyMarie Linder, Anders Ekbom, Gunnar Brobert, et al.
The Lancet. Respiratory Medicine|October 15, 2020
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death databaseStefano Barco, Luca Valerio, Walter Ageno, et al.
American Heart Journal|March 8, 2017
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trialC Michael Gibson, Rim Halaby, Serge Korjian, et al.
Research and Practice in Thrombosis and Haemostasis|October 22, 2024
Impact of the VTE-PREDICT calculator on clinicians' decision making in fictional patients with venous thromboembolism: a randomized controlled trialDaniël Duijzer, Maria A de Winter, Marc Carrier, et al.
Annals of Neurology|April 2, 2026
Network Colocalization Correlates of Depression and Anxiety in Pediatric Focal Cortical Dysplasia-Related EpilepsyXiaotong Li, Ty Charde, Venkata Sita Priyanka Illapani, et al.
Anesthesia and Analgesia|September 20, 1997
Single-dose ondansetron prevents postoperative vomiting in pediatric outpatientsR I Patel, P J Davis, R J Orr, et al.
Thrombosis and Haemostasis|May 22, 2015
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE studyJeffrey I Weitz, Rupert Bauersachs, Jan Beyer-Westendorf, et al.
Pageof 118

Showing results (1101-1110 of 1,179) with videos related to

Sort By:
Pageof 118
Thrombosis Research|November 26, 2016
Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trialsJan Beyer-Westendorf, Anthonie W A Lensing, Roopen Arya, et al.
Neurology|October 5, 2021
Hypothalamic Hamartomas: Evolving Understanding and ManagementNathan T Cohen, J Helen Cross, Alexis Arzimanoglou, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 18, 2015
Toxicity and clinical outcomes in patients with HIV on zidovudine and tenofovir based regimens: a retrospective cohort studySowmyanarayanan V Thuppal, Christine A Wanke, Farzad Noubary, et al.
Journal of Thrombosis and Thrombolysis|May 12, 2024
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register studyMarie Linder, Anders Ekbom, Gunnar Brobert, et al.
The Lancet. Respiratory Medicine|October 15, 2020
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death databaseStefano Barco, Luca Valerio, Walter Ageno, et al.
American Heart Journal|March 8, 2017
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trialC Michael Gibson, Rim Halaby, Serge Korjian, et al.
Research and Practice in Thrombosis and Haemostasis|October 22, 2024
Impact of the VTE-PREDICT calculator on clinicians' decision making in fictional patients with venous thromboembolism: a randomized controlled trialDaniël Duijzer, Maria A de Winter, Marc Carrier, et al.
Annals of Neurology|April 2, 2026
Network Colocalization Correlates of Depression and Anxiety in Pediatric Focal Cortical Dysplasia-Related EpilepsyXiaotong Li, Ty Charde, Venkata Sita Priyanka Illapani, et al.
Anesthesia and Analgesia|September 20, 1997
Single-dose ondansetron prevents postoperative vomiting in pediatric outpatientsR I Patel, P J Davis, R J Orr, et al.
Thrombosis and Haemostasis|May 22, 2015
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE studyJeffrey I Weitz, Rupert Bauersachs, Jan Beyer-Westendorf, et al.
Pageof 118